RBM3 as a marker for breast cancer prognosis

Details for Australian Patent Application No. 2009213167 (hide)

Owner ATLAS ANTIBODIES AB

Inventors Uhlen, Mathias; Jirstrom, Karin; Ponten, Fredrik

Agent Griffith Hack

Pub. Number AU-A-2009213167

PCT Pub. Number WO2009/102261

Priority 61/029,069 15.02.08 US; EP08151519.9 15.02.08 EP

Filing date 16 February 2009

Wipo publication date 20 August 2009

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/102261 Priority application(s): WO2009/102261

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009213175-Semi-submersible platform body for supporting drilling, storing, treatment or production of hydrocarbons at sea

2009213166-Telescopic lock